Literature DB >> 15821592

A method for producing overactive bladder in the rat and investigation of the effects of GABAergic receptor agonists and glutamatergic receptor antagonists on the cystometrogram.

Hitoshi Kontani1, Yasuyuki Ueda.   

Abstract

PURPOSE: We induced radio frequency (RF) lesions in the neuronal pathway leading from the forebrain to the pontine micturition center (PMC) to produce a rat model of bladder overactivity. We studied the effects of gamma-aminobutyric acid agonists (diazepam and baclofen) and glutamate receptor antagonists (MK-801 maleate and GYKI52466 [1-(4-aminophenyl-D-4-methyl-7,8 methylenedioxy-5H-2,3-benzodiazepine] hydrochloride) on the cystometrogram and developed a possible explanation of the neuronal mechanisms underlying RF lesion induced bladder overactivity. MATERIALS AND
METHOD: Seven-week-old male Sprague-Dawley rats were anesthetized with sodium pentobarbital and RF lesions were produced in the nuclei basalis. Five days later bladder contractions were induced by infusing fluid into the bladder and cystometrograms were measured in conscious rats.
RESULTS: The micturition interval (MI) in rats subjected to RF lesioning was significantly shorter than that in sham operated control rats. Diazepam (0.1 and 1 mg/kg intraperitoneally), baclofen (1 mg/kg intravenously) and MK-801 (0.1 and 1 mg/kg intravenously) did not change or shortened MI in control rats but it prolonged MI in lesioned rats. GYKI52466 (0.5 and 1 mg/kg intravenously) weakly prolonged MI in lesioned rats.
CONCLUSIONS: We consider that RF lesioning causes interruption of the inhibitory GABAergic neurons that lead from the forebrain to the PMC. This results in the activation of N-methyl-D-aspartate receptors in the PMC that are involved in the facilitation of voiding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821592     DOI: 10.1097/01.ju.0000154345.87935.a4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Inhibition of NMDAR reduces bladder hypertrophy and improves bladder function in cyclophosphamide induced cystitis.

Authors:  Miao Liu; Shanwei Shen; Derek M Kendig; Sunila Mahavadi; Karnam S Murthy; John R Grider; Li-Ya Qiao
Journal:  J Urol       Date:  2015-01-06       Impact factor: 7.450

2.  Nocturia: a blinded, randomized, parallel placebo-controlled self-study of the effect of 5 different sedatives and analgesics.

Authors:  Michael Kaye
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

3.  ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder.

Authors:  M Kalinichev; S Palea; H Haddouk; I Royer-Urios; V Guilloteau; P Lluel; M Schneider; M Saporito; S Poli
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice.

Authors:  Xiang Xie; Chuang Luo; Jia Yu Liang; Run Huang; Jia Li Yang; Linlong Li; YangYang Li; Hongming Xing; Huan Chen
Journal:  PeerJ       Date:  2021-07-07       Impact factor: 2.984

5.  Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis.

Authors:  Masako Hashimoto; Kanako Hashimoto; Fumihiko Ando; Yoshiaki Kimura; Keisuke Nagase; Kunizo Arai
Journal:  J Pharm Health Care Sci       Date:  2015-02-15

6.  Systemic and intrathecal baclofen produce bladder antinociception in rats.

Authors:  Timothy J Ness; Alan Randich; Xin Su; Cary DeWitte; Keith Hildebrand
Journal:  BMC Urol       Date:  2021-10-04       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.